MicroPort CardioFlow Medtech Corporation provided group earnings guidance for the year ended December 31, 2022. For the period, the Group is expected to record a revenue of no less than RMB 250 million for the year ended December 31, 2022, representing an increase of approximately 25% as compared to that of the year ended December 31, 2021 and, net loss of approximately RMB 440 million to RMB 470 million for the year ended December 31, 2022, compared to approximately RMB 183 million for the year ended December 31, 2021.
MicroPort CardioFlow Medtech Corporation
Equities
2160
KYG6082P1054
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 HKD | +0.97% | +11.83% | -35.80% |
Apr. 16 | Microport Cardioflow Inks Services Deal with Subsidiary | MT |
Apr. 15 | MicroPort CardioFlow Medtech Corporation Enters into the 2024 MP CardioAdvent Service Procurement Framework Agreement | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.80% | 317M | |
+13.16% | 128B | |
-8.76% | 10.65B | |
+3.60% | 8.82B | |
+19.75% | 7.19B | |
+22.28% | 4.99B | |
+7.55% | 3.4B | |
-0.21% | 3.03B | |
-4.80% | 2.14B | |
-4.72% | 2B |
- Stock Market
- Equities
- 2160 Stock
- News MicroPort CardioFlow Medtech Corporation
- MicroPort CardioFlow Medtech Corporation Provides Group Earnings Guidance for the Year Ended December 31, 2022